Charity investor the Wellcome Trust has launched Syncona Partners, an investment subsidiary managing a £200m ($329m) evergreen fund.

Previously announced as Project Sigma by the Trust in March 2012, Syncona will be focused on supporting development of sustainable healthcare businesses. The UK-based fund will invest globally, with investments ranging from between £1m to £20m. Syncona will invest at both early and late stage, and as a lead investor or as part of a syndicate.

The company has already added two…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?